Copyright Reports & Markets. All rights reserved.

Global and United States HIV Vaccines Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global HIV Vaccines Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Phase I
    • 1.2.3 Phase II
    • 1.2.4 Phase III
  • 1.3 Market by Application
    • 1.3.1 Global HIV Vaccines Market Share by Application: 2020 VS 2026
    • 1.3.2 Research Institute
    • 1.3.3 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global HIV Vaccines Market Perspective (2015-2026)
  • 2.2 Global HIV Vaccines Growth Trends by Regions
    • 2.2.1 HIV Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 HIV Vaccines Historic Market Share by Regions (2015-2020)
    • 2.2.3 HIV Vaccines Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top HIV Vaccines Players by Market Size
    • 3.1.1 Global Top HIV Vaccines Players by Revenue (2015-2020)
    • 3.1.2 Global HIV Vaccines Revenue Market Share by Players (2015-2020)
  • 3.2 Global HIV Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by HIV Vaccines Revenue
  • 3.4 Global HIV Vaccines Market Concentration Ratio
    • 3.4.1 Global HIV Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by HIV Vaccines Revenue in 2019
  • 3.5 Key Players HIV Vaccines Area Served
  • 3.6 Key Players HIV Vaccines Product Solution and Service
  • 3.7 Date of Enter into HIV Vaccines Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 HIV Vaccines Breakdown Data by Type (2015-2026)

  • 4.1 Global HIV Vaccines Historic Market Size by Type (2015-2020)
  • 4.2 Global HIV Vaccines Forecasted Market Size by Type (2021-2026)

5 HIV Vaccines Breakdown Data by Application (2015-2026)

  • 5.1 Global HIV Vaccines Historic Market Size by Application (2015-2020)
  • 5.2 Global HIV Vaccines Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America HIV Vaccines Market Size (2015-2026)
  • 6.2 North America HIV Vaccines Market Size by Type (2015-2020)
  • 6.3 North America HIV Vaccines Market Size by Application (2015-2020)
  • 6.4 North America HIV Vaccines Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe HIV Vaccines Market Size (2015-2026)
  • 7.2 Europe HIV Vaccines Market Size by Type (2015-2020)
  • 7.3 Europe HIV Vaccines Market Size by Application (2015-2020)
  • 7.4 Europe HIV Vaccines Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China HIV Vaccines Market Size (2015-2026)
  • 8.2 China HIV Vaccines Market Size by Type (2015-2020)
  • 8.3 China HIV Vaccines Market Size by Application (2015-2020)
  • 8.4 China HIV Vaccines Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan HIV Vaccines Market Size (2015-2026)
  • 9.2 Japan HIV Vaccines Market Size by Type (2015-2020)
  • 9.3 Japan HIV Vaccines Market Size by Application (2015-2020)
  • 9.4 Japan HIV Vaccines Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia HIV Vaccines Market Size (2015-2026)
  • 10.2 Southeast Asia HIV Vaccines Market Size by Type (2015-2020)
  • 10.3 Southeast Asia HIV Vaccines Market Size by Application (2015-2020)
  • 10.4 Southeast Asia HIV Vaccines Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Argos Therapeutics
    • 11.1.1 Argos Therapeutics Company Details
    • 11.1.2 Argos Therapeutics Business Overview
    • 11.1.3 Argos Therapeutics HIV Vaccines Introduction
    • 11.1.4 Argos Therapeutics Revenue in HIV Vaccines Business (2015-2020))
    • 11.1.5 Argos Therapeutics Recent Development
  • 11.2 Bionor Pharma
    • 11.2.1 Bionor Pharma Company Details
    • 11.2.2 Bionor Pharma Business Overview
    • 11.2.3 Bionor Pharma HIV Vaccines Introduction
    • 11.2.4 Bionor Pharma Revenue in HIV Vaccines Business (2015-2020)
    • 11.2.5 Bionor Pharma Recent Development
  • 11.3 Janssen Global Services
    • 11.3.1 Janssen Global Services Company Details
    • 11.3.2 Janssen Global Services Business Overview
    • 11.3.3 Janssen Global Services HIV Vaccines Introduction
    • 11.3.4 Janssen Global Services Revenue in HIV Vaccines Business (2015-2020)
    • 11.3.5 Janssen Global Services Recent Development
  • 11.4 Genecure
    • 11.4.1 Genecure Company Details
    • 11.4.2 Genecure Business Overview
    • 11.4.3 Genecure HIV Vaccines Introduction
    • 11.4.4 Genecure Revenue in HIV Vaccines Business (2015-2020)
    • 11.4.5 Genecure Recent Development
  • 11.5 Geovax,
    • 11.5.1 Geovax, Company Details
    • 11.5.2 Geovax, Business Overview
    • 11.5.3 Geovax, HIV Vaccines Introduction
    • 11.5.4 Geovax, Revenue in HIV Vaccines Business (2015-2020)
    • 11.5.5 Geovax, Recent Development
  • 11.6 Paxvax Corporation
    • 11.6.1 Paxvax Corporation Company Details
    • 11.6.2 Paxvax Corporation Business Overview
    • 11.6.3 Paxvax Corporation HIV Vaccines Introduction
    • 11.6.4 Paxvax Corporation Revenue in HIV Vaccines Business (2015-2020)
    • 11.6.5 Paxvax Corporation Recent Development
  • 11.7 Inovio Pharmaceuticals
    • 11.7.1 Inovio Pharmaceuticals Company Details
    • 11.7.2 Inovio Pharmaceuticals Business Overview
    • 11.7.3 Inovio Pharmaceuticals HIV Vaccines Introduction
    • 11.7.4 Inovio Pharmaceuticals Revenue in HIV Vaccines Business (2015-2020)
    • 11.7.5 Inovio Pharmaceuticals Recent Development
  • 11.8 Glaxosmithkline
    • 11.8.1 Glaxosmithkline Company Details
    • 11.8.2 Glaxosmithkline Business Overview
    • 11.8.3 Glaxosmithkline HIV Vaccines Introduction
    • 11.8.4 Glaxosmithkline Revenue in HIV Vaccines Business (2015-2020)
    • 11.8.5 Glaxosmithkline Recent Development
  • 11.9 Sanofi
    • 11.9.1 Sanofi Company Details
    • 11.9.2 Sanofi Business Overview
    • 11.9.3 Sanofi HIV Vaccines Introduction
    • 11.9.4 Sanofi Revenue in HIV Vaccines Business (2015-2020)
    • 11.9.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global HIV Vaccines Scope and Market Size
    HIV Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HIV Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Phase I
    Phase II
    Phase III

    Market segment by Application, split into
    Research Institute
    Other

    Based on regional and country-level analysis, the HIV Vaccines market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global HIV Vaccines market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Argos Therapeutics
    Bionor Pharma
    Janssen Global Services
    Genecure
    Geovax,
    Paxvax Corporation
    Inovio Pharmaceuticals
    Glaxosmithkline
    Sanofi

    Buy now